Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Flavonols, a subclass of flavonoids found abundantly in fruits, vegetables, tea, and cocoa, are increasingly studied for their potential cardiovascular benefits. Scientific evidence, primarily from epidemiological and clinical studies, suggests that a higher intake of flavonol-rich foods is associated with a reduced risk of cardiovascular disease (CVD). The mechanisms attributed to flavonols include antioxidant effects, improvement of endothelial function, anti-inflammatory properties, and inhibition of platelet aggregation. For example, quercetin and kaempferol, two well-known flavonols, have demonstrated abilities to reduce oxidative stress and improve vascular health in both animal models and human studies. Meta-analyses of randomized controlled trials indicate that flavonol supplementation can modestly lower blood pressure and improve markers of endothelial function, which are key factors in cardiovascular health. However, most clinical studies use flavonol-rich extracts or foods rather than isolated flavonols, and the observed effects are generally modest. While the overall body of evidence supports the cardiovascular benefits of flavonol consumption, especially as part of a diet rich in plant-based foods, more large-scale, high-quality clinical trials are needed to establish definitive recommendations regarding supplementation. Thus, the use of flavonols for cardiovascular disease has a reasonable scientific basis, though the evidence is moderate rather than conclusive.

More about flavonols
More about Cardiovascular Disease

Other ingredients used for Cardiovascular Disease

Other health conditions supported by flavonols

Products containing flavonols